IN8bio share price logo

IN8bio

NASDAQ: INAB

$1.42

+0.02

(+1.43%)

as on

IN8bio Stock Performance

as on October 6, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.38
    $1.45
    downward going graph

    2.82%

    Downside

    2.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.88
    $2.73
    downward going graph

    38.03%

    Downside

    92.25%

    Upside

    downward going graph

IN8bio share price movements today

Previous Close
$1.40
Open
$1.40
Volume
593.5K
Market Cap
$13.8M
Day's Low - High
$1.38 - $1.45
52 Week Low - High
$0.88 - $2.73

IN8bio Historical Returns

1 Month Return
+ 18.33 %
3 Month Return
-1.39 %
1 Year Return
-39.57 %
3 Year Return
-95.02 %
5 Year Return
-99.25 %

IN8bio Stock Fundamentals & Key Indicators

Check IN8bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.8M

EPS (TTM)

-1.87

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.75

Industry PE ratio

-3.20

PEG Ratio

-0.00

EBITDA

-16.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-91.18%

IN8bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IN8bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$13.8M-99.25%-0.750.00%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for IN8bio Stock including INR - Dollar returns

The IN8bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

IN8bio investment value today

Current value as on today

₹65,582

Returns

-₹34,418

(-34.42%)

Returns from IN8bio Stock

-₹39,574 (-39.57%)

Dollar Impact

₹5,157 (+5.16%)

Analyst Recommendation on IN8bio Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for IN8bio. Average target price of $7

IN8bio Share Price Target

Get share price movements and forecasts by analysts on IN8bio.

What analysts predicted

79.71%UPSIDE

Target Price

$7

Current Price

$1.42

Analyzed by

2 Analysts

High

$6

Target

$7.00

Low

$5

IN8bio target price $7, a slight upside of 79.71% compared to current price of $1.42. According to 2 analysts rating.

Indian Investors' Interest in IN8bio Stock

Search interest for IN8bio Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

IN8bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
-
Operating Income
-8
-8
-7
-6
-5
-5
-3
-4
-5
-4
EBITDA
-8
-8
-5
-5
-4
-4
-3
-4
-4
-4
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-8
-7
-6
-5
-5
-3
-4
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-8
-7
-6
-5
-5
-3
-4
-5
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

IN8bio Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-2
-
-2
Operating Income
-2
-5
-8
-14
-28
-30
-30
-19
EBITDA
-1
-5
-8
-13
-27
-27
-26
-16
Interest Expense
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
1
2
2
2
Income Before Tax
-2
-5
-8
-14
-28
-30
-30
-19
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-2
-5
-8
-14
-28
-30
-30
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

IN8bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-8
-7
-6
-5
-5
-3
-4
-5
-4
Operating Cash Flow
-7
-6
-6
-4
-3
-3
-3
-2
-4
-3
Investing Cash Flow
0
0
-
0
-
-
-
-
0
0
Financing Cash Flow
0
3
0
11
3
5
0
18
0
0
Change in Cash
-8
-2
-6
7
0
1
-2
16
-5
-4

IN8bio Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-5
-8
-14
-28
-30
-30
-19
Operating Cash Flow
-2
-4
-7
-13
-24
-23
-24
-12
Investing Cash Flow
0
0
-
0
-3
0
0
-
Financing Cash Flow
8
0
24
32
8
27
14
28
Change in Cash
4
-4
17
19
-18
3
-10
15

Global Institutional Holdings in IN8bio

Check out the Institutions with significant holdings in IN8bio.

Funds
Holdings
Franklin Strategic Series
3.37%
VANGUARD INDEX FUNDS
0.90%
Vanguard
0.90%
Fidelity Concord Street Trust
0.22%

Insights on IN8bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, INAB stock has moved up by 9.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 677.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 95.6% return, outperforming this stock by 190.6%

About IN8bio

IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer. The company's primary therapeutic asset, INB-200, is an autologous (patient-derived) gamma-delta T cell product that has been genetically engineered and is presently undergoing a Phase I clinical study for glioblastoma and other solid tumor malignancies. Additionally, INB-100, an allogeneic (donor-derived) candidate, is also in a Phase I clinical trial, aiming to treat acute leukemia patients undergoing hematopoietic stem cell transplantation. Further development includes preclinical programs, INB-400 and INB-300, which are designed to address a range of solid tumor cancers. Established in 2016, the company initially operated as Incysus Therapeutics, Inc. before changing its name to IN8bio, Inc. in August 2020. Its corporate headquarters are located in New York, New York.
OrganisationIN8bio
Headquarters350 5th Avenue, New York City, NY, 10118, US
IndustryBiotechnology
CEOWilliam T.

Key Management of IN8bio

Name

Title

Mr. Tai-Wei Ho

Co-Founder, CEO & Director

Dr. Kate Rochlin Ph.D.

President & COO

Mr. Patrick McCall CPA

CFO & Secretary

Dr. Lawrence S. Lamb Ph.D.

Executive VP, Co-Founder & Chief Scientific Officer

Dr. Oxana Polyakova Ph.D.

Senior Vice President of Research & Development

FAQs

What is IN8bio share price today?

IN8bio share price today is $1.42 as on at the close of the market. IN8bio share today touched a day high of $1.45 and a low of $1.38.

What is the 52 week high and 52 week low for IN8bio share?

IN8bio share touched a 52 week high of $2.73 on and a 52 week low of $0.88 on . IN8bio stock price today i.e. is closed at $1.42,which is 47.99% down from its 52 week high and 61.36% up from its 52 week low.

What is IN8bio's market capitalisation today?

IN8bio market capitalisation is $0.00T as on .

How to invest in IN8bio Stock (INAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for IN8bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy IN8bio Stock (INAB) from India?

Indian investors can start investing in IN8bio (INAB) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in IN8bio stock (as per the Rupee-Dollar exchange rate as on ). Based on IN8bio share’s latest price of $1.42 as on October 6, 2026 at 8:46 am IST, you will get 7.0423 shares of IN8bio. Learn more about fractional shares .

What are the returns that IN8bio has given to Indian investors in the last 5 years?

IN8bio stock has given -99.25% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?